Abstract
Transition from antepartum to postpartum care is important, but often fragmented, and attendance at postpartum visits can be poor. Access to care is especially important for individuals diagnosed antepartum with conditions associated with longer-term implications, including gestational diabetes (GDM) and hypertensive disorders in pregnancy (HDP). Strategies to link and strengthen this transition are essential to support people to attend recommended appointments and testing. This narrative review evaluates what is known about postpartum transition of care after higher-risk antepartum conditions, discusses barriers and facilitators to uptake of recommended testing, and outlines strategies trialled to increase both postpartum attendance and testing. Barriers to attendance frequently overlap with general barriers to accessing healthcare. Specific postpartum challenges include difficulties with transport, coordinating breastfeeding and childcare access. Systemic challenges include inadequate communication to women around implications of health conditions diagnosed in pregnancy, and the importance of postpartum follow up. Uptake of recommended testing after a diagnosis of GDM and HDP is variable but generally suboptimal. Strategies which demonstrate promise include the use of patient navigators, focused education and specialised clinics. Reminder systems have had variable impact. Telehealth and technology are under-utilised in this field but offer promising options particularly with the expansion of virtual healthcare into routine maternity care. Strategies to improve both attendance rates and uptake of testing must be designed to address disparities in healthcare access and tailored to the needs of the community. This review provides a starting point to develop such strategies from the community level to the population level.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Current recommendations for postpartum care
The postpartum period begins at birth and is defined as the first 6 [1] to 12 [2] weeks after delivery, sometimes referred to as the fourth trimester. Postpartum review with a healthcare practitioner plays a significant role in supporting those with immediate health needs including contraception, breastfeeding, peripartum mental health, and wound care [1, 3]. Most guidelines recommend this visit takes place at or prior to 6 weeks’ postpartum [1].
Despite this recommendation, documented low attendance rates at the postpartum visit suggest that many people do not receive this important review in a timely manner [4]. Contributing factors to this include inconsistently defined care pathways supporting people in the transition from antepartum to postpartum care, fragmented communication between healthcare providers and competing priorities.
Many pregnant people are diagnosed for the first time with a medical condition during pregnancy. Conditions such as gestational diabetes (GDM) and hypertensive disorders of pregnancy (HDP) have implications for longer term health and ongoing engagement in healthcare and postpartum testing is recommended following these diagnoses. GDM, defined as the first presentation of hyperglycaemia in pregnancy, affects 14% of pregnancies worldwide [5] and is predictive of an increased risk of metabolic disorders including a seven- to ten-fold risk of type 2 diabetes within 10 years [6]. An oral glucose tolerance test (OGTT) is recommended for those with a diagnosis of GDM within the first 12 weeks’ postpartum [2] and at regular intervals thereafter to provide opportunity for early diagnosis and treatment of type 2 diabetes mellitus.
The spectrum of HDP includes gestational hypertension, pre-eclampsia, eclampsia, chronic hypertension and pre-eclampsia superimposed on chronic hypertension [7]. Global prevalence is estimated at 116 cases per 100,000 women of childbearing age, with the highest rates seen in low-income countries at 286 cases per 100,000 compared with 70 cases per 100,000 in high-income countries [8]. HDP are associated with long-term cardiovascular, cerebrovascular and renal disease [9, 10], and blood pressure review is recommended in the first 7–10 days postpartum [7]. Testing for persistent hypertension, markers of organ dysfunction (e.g. urinalysis for proteinuria, renal and liver function testing), ambulatory blood pressure monitoring, metabolic screening with fasting glucose, lipid profile and body mass index measurement, within 3–6 months is advised, and at regular intervals thereafter [11].
Both chronic medical illness [12] and new antepartum diagnoses of medical conditions [13] are associated with poorer peripartum mental health. Those with GDM have a significantly increased risk of postpartum depressive symptoms, with an estimated pooled relative risk of 1.32 [14]. Pre-eclampsia has been identified as a risk factor for depression both during the postpartum period, and beyond [15]. The relationship between other HDP and poor peripartum mental health is less clear, but trends towards increased risk of depression, anxiety and post-traumatic stress disorder have been reported [16]. Postpartum review provides an important opportunity for screening and support for peripartum mental health disorders.
This state of the science review summarises what is known about rates of postpartum engagement in care both nationally and internationally, as defined by attendance at the 6-week postpartum visit, and uptake of recommended testing in those with medical diagnoses of GDM and HDP during pregnancy. We outline the strategies trialled to date to improve attendance at postpartum visits and improve adherence to recommended testing; the barriers and facilitators to uptake of recommended testing; and discuss gaps in the literature for future research.
Attendance postpartum: what is known?
Attendance rates for postpartum care vary significantly between different cohorts, countries, and healthcare systems. Whilst a 6-week appointment is recommended, few studies report attendance rates at this time point. Attendance rates of 42% at the maternal 6-week check have been reported in the United Kingdom (U.K.) by 6–8 weeks postpartum, increasing to 62% by 12 weeks [17]. In the United States (U.S.), reported rates vary from 54% in the first year postpartum amongst veterans [18], to 72% in a recent systematic review [4], and to more than 80% by 90 days postpartum amongst women with funded postpartum care [19]. In Australia, 81% attendance at a general practitioner visit was reported in a South Australian cohort in the first 9 months postpartum [20]. Disparities in attendance rates exist within these countries, with significantly lower attendance rates in the U.S. among those of Black/African American (52%), Asian (45%) and Hawaiian/other Pacific Islander (48%) race and ethnicity [18]. Similarly, in Australia attendance was lower (48%) amongst Aboriginal and Torres Strait Islander people attending rural health services [21], suggesting multiple factors contributing to non-attendance. Access to health insurance in countries such as the U.S. also impact on attendance at postpartum visits, with Medicaid-insured women less likely to attend than those with private insurance [4]. Concurrent existence of a chronic condition has also been found to reduce the likelihood of attending the postpartum visit [4].
What strategies have been trialled to increase postpartum attendance?
A variety of strategies have been trialled in different settings to increase postpartum attendance. The different types of approaches are discussed by Phillips et al. [22] in their recent review of postpartum transition of care, and strategies trialled to date were described by Stumbras et al. [23] in their 2016 narrative review. As these summaries provide an excellent overview of strategies to improve postpartum transition of care, an in-depth analysis is not repeated in our review. For the purposes of understanding what has been identified to date, Table 1 summarises these strategies with examples of their use to increase postpartum attendance.
Patient incentives, patient education and home visits have generally shown mixed success at increasing attendance. Patient navigator systems appear more successful at increasing attendance as well as other parameters including vaccination uptake and screening for depression [33]. This may be due to the ability to tailor such strategies towards individual needs. A systematic review and meta-analysis by Bowden et al. [34] of strategies in high-income countries and their impact on antepartum and postpartum care found that people who received enhanced support with individualised care were significantly more likely to attend their postpartum visit. This conclusion was based on aggregate data using two very different strategies: patient incentives [27] and patient navigators [29]. The use of administrative assistance such as pre-discharge appointment scheduling has also been associated with promising results [24] but has yet to be trialled prospectively as a strategy in its own right.
More recently, the use of technology has allowed the opportunity to expand strategies beyond reminder-based messaging alone, for example to incorporate remote blood pressure monitoring [35], and education delivery [32]. Use of technology within the postpartum setting to specifically increase attendance rates has yet to be explored definitively particularly in high-income settings. Preliminary findings from a series of qualitative interviews for people who received text-based messaging from their postpartum healthcare provider indicated that this approach was viewed positively by participants [32].
Many programmes combine two or more of these approaches within their postpartum care set-up. For example, Health Beyond Pregnancy [30] used text-based reminder systems to prompt postpartum follow-up, with additional motivational messaging via video and text, and also used a cash incentive which was provided to those who attended their visit. This multi-approach focus may be helpful in broadening the reach of individual programmes; however, there is insufficient evidence to identify which combinations of approaches are most likely to be successful in increasing attendance rates. Feasibility assessment and economic evaluation of these combined approaches are also an essential part of service evaluation and data remains sparse on this topic.
Uptake of postpartum testing: what is known?
Recommended postpartum testing for those with GDM includes an OGTT within the first 12 weeks [2], and for those with HDP, a blood pressure measurement within 7–10 days [7], followed by more comprehensive testing with proteinuria analysis, ambulatory blood pressure testing and metabolic screening [11]. However, postpartum testing rates after antepartum diagnoses such as GDM and HDP are frequently suboptimal.
A systematic review of studies analysing postpartum testing rates after GDM identified aggregate rates of 48% [36], with a further systematic review focusing on studies published in the U.S. setting since 2011 finding testing rates of 58% at best, and frequently lower, by 3 years postpartum [37]. Analysis from a large university-insurance collaborative data repository in the U.S. identified much lower testing rates after GDM diagnosis with just 6% undergoing any type of glucose testing by 8 weeks postpartum, 22% by 1 year and 51% by 3 years [38]. Blood pressure screening within 6 weeks of delivery after HDP also varies, with observational studies from the U.S., reporting ranges from 33.5% [39], to 52% [40]. A further evaluation of women attending a 3-month study visit found that despite high rates of blood pressure testing (98%) in this group, far fewer (< 60%) had further testing with lipid screening [41]. National data in other high-income settings is sparse.
In Australia, those diagnosed with diabetes are encouraged and assisted to register with the National Diabetes Services Scheme (NDSS); registrants are invited to being contacted for research purposes using an opt-in model of consent [42]. A survey of responses among those registered to the NDSS with GDM identified that 73% underwent postpartum diabetes testing, but of these, only 27% underwent OGTT prior to 8 weeks’ postpartum [42]. Lower rates were reported in more remote regions of Australia, with 14% of Indigenous people, and 28% of non-Indigenous people undergoing OGTT by 6 months postpartum [43]. Health inequities in this study were identified beyond testing rates, with Indigenous people experiencing significantly longer times to any postpartum glucose test [43]. A large retrospective study reviewed the follow up of over 10,000 women with GDM from an estimated 12 weeks’ postpartum, until over 4 years postpartum, and found that 29% had not been assessed for diabetes [44]. This study excluded the postpartum period in order to highlight practices of long-term screening, finding that longer term follow-up also remains suboptimal [44]. The authors also found that 6% of the whole cohort received a new diagnosis of diabetes within this timeframe, highlighting the importance of testing in the postpartum period and beyond [44]. In terms of follow up of HDP in the postpartum period, 94.5% of a group of women with diagnosis of pre-eclampsia in the previous 2 years reported blood pressure measurement since birth, but screening for metabolic abnormalities occurred in less than half [45].
Factors associated with adherence to recommended testing
In order to identify why some strategies work better than others, it is essential to understand the facilitators and barriers for uptake of testing. Several individual, sociodemographic and systemic factors contribute to the ability and prioritisation of engagement in care (Table 2).
Many of the identified barriers are frequently associated with worse health outcomes across the life course, and often co-exist with each other. For example, people with GDM of high socioeconomic status are more easily able to overcome financial barriers to undergoing oral glucose tolerance testing [53], and those who live rurally [52], or in an area of deprivation [47], are more likely to experience barriers to uptake of testing. Black and Hispanic individuals are over-represented among people with the diagnosis of GDM and HDP [54] yet have lower rates of uptake of postpartum testing [55]. The presence of structural racism within policy and institutional practices may exacerbate such disparities [54]. There is a need to provide tailored, culturally sensitive strategies which factor in social determinants of health.
For many, the logistics of attending for testing present barriers, for example accessibility issues for those requiring childcare and breastfeeding facilities [49], and the time involved in undergoing an OGTT [50]. There is conflicting data on the relationship between undergoing postpartum testing, and factors such as maternal age [28, 36, 37, 40, 42, 47], requirement for insulin for GDM management [36, 46, 47, 56], and the timing of first presentation for antepartum care [37, 51].
What strategies have been trialled to improve postpartum testing rates in higher-risk groups?
Table 3 presents an overview of strategies trialled within the antepartum and postpartum periods with the aim of increasing postpartum testing after GDM and HDP.
A limited number of strategies have been implemented in the antepartum period with the aim of improving postpartum testing rates. These include focused antepartum education [55], and use of care co-ordinators [46, 57], and in all studies have improved testing rates. Strategies implemented postpartum have been more widely trialled. Reminder systems (to people with GDM or HDP, their clinicians or both) have been examined with mixed outcomes [56, 60,61,62,63, 68]. Reminder systems where clinicians also received reminders, and which were implemented in the early postpartum period, appeared to achieve better testing rates.
Other successful approaches include the use of postpartum patient care co-ordinators and patient navigators. These roles may overlap: we define care co-ordination as a role that focuses on the provision of individualised care such as co-ordinating appointments and following up to ensure attendance, but which does not necessarily extend to in-person assistance; whereas patient navigators provide longitudinal care, often attending appointments with women, and provide a more culture-specific service. Both these strategies have been found to increase postpartum GDM testing [28] and early surveillance in people with chronic hepatitis B infection, another condition frequently diagnosed antepartum requiring long-term co-ordination of care [59].
Administrative assistance in booking testing and appointments has not been trialled extensively and understanding of the potential benefits of this approach remain limited. One study found improvement in testing rates in a small population with GDM when this approach was combined with patient incentives [58]. Specialist postpartum clinics have been trialled in those with HDP to facilitate transition to ongoing primary care follow-up, with financial viability and attendance rates of 85% demonstrated in one clinic providing intensive monitoring in the early postpartum period, including provision of home blood pressure monitoring resources [48]. Another multidisciplinary clinic providing both in-person and virtual care to women at a median of 11 weeks postpartum, had attendance rates of 80%, and included blood pressure testing for all attendees at the time of the visit, and lipid panel testing forms provided for metabolic screening [64]. Uptake of lipid testing for clinic attendees was low, at 53%, although no baseline rate was available for comparison [64]. No difference was identified in clinic attendance rates, nor postpartum lipid testing between those who attended virtually versus face to face [64]. Finally, models of care which integrate parent and infant postpartum visits into the same appointment have demonstrated variable success in improving rates of postpartum glucose testing [65, 67].
The use of Telehealth provides opportunities for flexible modalities of service delivery. As discussed, a hybrid clinic found no difference in either uptake of clinic use as measured by attendance rates, nor in metabolic screening, between participants who received virtual versus face to face care [64]. Use of remote monitoring of blood pressure has also been trialled for people with HDP, with successful outcomes in early testing [35] but not 6-week visit attendance [66]. Integration of technology as part of multi-approach programmes may enhance overall outcomes and is deserving of further attention.
Tailoring strategies to optimise adherence to testing
Higher adherence to testing recommendations were seen with strategies which personalised healthcare, provided education and addressed individual barriers, such as through use of patient navigators, provision of environments which supported childcare and breastfeeding, and reduced time burden of testing [49]. This suggests that consumers are motivated to engage in healthcare when they are supported to do so according to their individual needs. Personalised healthcare, for example by use of a patient navigator to support individual needs, can also address a number of the barriers to accessing care, and care can be tailored in a way that allows equitable access.
Telehealth provides an opportunity to overcome the time and financial burden associated with travel and childcare, but introduces risk of further inequity via the digital divide if cost of technology and device access is placed on the individual [69]. For women who do not speak English, the logistics of ensuring adequate access to interpreters within the telehealth setting can add another layer of complexity. Furthermore, there may be unintended consequences of telehealth appointments including missed opportunities for screening, vaccination and physical examination. Care must be taken when designing and evaluating initiatives to ensure that unintended consequences that widen gaps in healthcare access do not occur.
Limited qualitative data exists on what consumers of postpartum care want and need after diagnosis of high-risk conditions to enable them to access recommended testing. A cross-sectional telephone survey of people with GDM in Australia explored the barriers to post-partum screening in detail [49]. Logistic challenges such as the time burden of doing a two-hour OGTT and childcare access featured prominently. These concerns were echoed in an earlier study which also identified that many participants either perceived they were ‘healthy’ or were fearful about receiving a diagnosis of type 2 diabetes after postpartum glucose testing [70]. With any programme designed to improve engagement in healthcare, it is essential to understand the needs and wishes of the intended consumers. Involvement of consumers in the developmental stages of such programmes, and feedback from those who receive care as part of an evaluation process, are recommended.
Key findings
The postpartum period, or the ‘fourth trimester’, provides a unique healthcare opportunity, when otherwise mostly healthy people access healthcare regularly. Many pregnant people will receive an antepartum diagnosis associated with potential longer-term adverse health outcomes. Primary prevention can be implemented to reduce these risks and/or delay onset. However, this must be provided equitably and address disparities in healthcare access within the highest risk populations.
Despite several different strategies trialled in a wide variety of populations, there is not conclusive data on the best method to improve attendance at postpartum appointments and to engage those with high-risk conditions in longer-term follow-up.
Strategies that have shown promise include: focused antepartum education, for example with a diabetes educator [55], nutritionist, or with education booklets [57]; use of patient care co-ordinators providing assistance with booking testing appointments and following up those who did not attend to arrange in-home testing [28, 46]; and patient navigators providing individualised assistance with education, co-ordination of testing, and assistance to attend [59].
In addition, creating environments for postpartum testing which support the unique needs of parents with young infants, such as provision of breastfeeding-friendly spaces with options for childcare, may help reduce inequities in access [49]. Systems which facilitate remote testing opportunities, for example blood pressure measurements, can help reduce geographical and transport barriers. The expanding field of telemedicine has yet to be fully realised in this area of healthcare but has potential to enhance systemic provision of care.
Avenues for future research
Several gaps have been identified requiring further research. Firstly, the data around both rates of postpartum follow-up at the routine postpartum check and uptake of recommended testing in those at higher risk of long-term conditions is limited to a small number of geographical areas and does not capture national rates. Estimations of the scale of these issues are essential to healthcare and resource planning.
Secondly, careful thought is required about how to provide effective, scalable strategies to support people at this uniquely challenging time, and which provide an opportunity to empower them in managing their immediate and longer-term health. Thirdly, many programmes employ nursing and allied health practitioners such as social workers and administrative staff to provide education and care, with most of these based within the hospital system. Integration with existing community services beyond primary care practitioners may help broaden access, such as through community pharmacists and pathology testing centres.
Further, the role of telemedicine requires further exploration particularly in settings with geographical barriers to care and for those with challenges to in-person attendance such as childcare needs. The potential for remote monitoring, for example with blood pressure and blood glucose level testing, are areas of promise.
Finally, the needs of populations with specific health, cultural and equity imbalances must be reviewed in depth, and consumers from these groups included in co-design and evaluation of strategies.
Quick points
-
Postpartum pathways of care are poorly defined and attendance at recommended visits is often suboptimal
-
Uptake of recommended testing after high-risk conditions including gestational diabetes and hypertensive disorders of pregnancy is low
-
Barriers to uptake of testing include individual, sociodemographic and systemic factors which often overlap with drivers of inequity in access to healthcare in general
-
Strategies to improve adherence to recommended testing include specialist postpartum clinics, patient education and the use of patient navigators
-
Further research into engagement with healthcare, and optimal strategies to support postpartum populations including through a culturally sensitive and equitable lens are urgently required
References
Milroy T, Frayne J (2022) Postnatal care: the general practitioner visit. Aust J Gen Pract 51(3):105–110. https://doi.org/10.31128/AJGP-02-21-5835
Paladine HL, Blenning CE, Strangas Y (2019) Postpartum care: an approach to the fourth trimester. Am Fam Physician 100(8):485–491
World Health Organization. (2013) WHO recommendations on postnatal care of the mother and newborn. Geneva, CH: WHO. https://iris.who.int/bitstream/handle/10665/97603/9789241506649_eng.pdf?sequence=1. Accessed 26 March 2024.
Attanasio LB, Ranchoff BL, Cooper MI, Geissler KH (2022) Postpartum visit attendance in the United States: a systematic review. Womens Health Issues 32(4):369–375. https://doi.org/10.1016/j.whi.2022.02.002
Wang H, Li N, Chivese T et al (2022) IDF Diabetes Atlas: estimation of global and regional gestational diabetes mellitus prevalence for 2021 by International Association of Diabetes in Pregnancy Study Group’s criteria. Diabetes Res Clin Pract 183:109050. https://doi.org/10.1016/j.diabres.2021.109050
Clark HD, Keely E (2012) Getting mothers with gestational diabetes to return for postpartum testing: what works and what does not. Diabetes Manage 2(1):33–39
Booker WA (2020) Hypertensive disorders of pregnancy. Clin Perinatol 47(4):817–833. https://doi.org/10.1016/j.clp.2020.08.011
Jiang L, Tang K, Magee LA et al (2022) A global view of hypertensive disorders and diabetes mellitus during pregnancy. Nat Rev Endocrinol 18(12):760–775. https://doi.org/10.1038/s41574-022-00734-y
Melchiorre K, Thilaganathan B, Giorgione V, Ridder A, Memmo A, Khalil A (2020) Hypertensive disorders of pregnancy and future cardiovascular health. Front Cardiovasc Med 7:59. https://doi.org/10.3389/fcvm.2020.00059
Davis GK, Henry A, Arnott C, Brown MA (2021) The long-term cardiovascular impact of hypertension in pregnancy—a missed opportunity. Aust N Z J Obstet Gynaecol 61(3):474–477. https://doi.org/10.1111/ajo.13335
Poon LC, Nguyen-Hoang L, Smith GN et al (2023) Hypertensive disorders of pregnancy and long-term cardiovascular health: FIGO Best Practice Advice. Int J Gynaecol Obstet 160(S1):22–34. https://doi.org/10.1002/ijgo.14540
Brown HK, Qazilbash AM, Rahim N, Dennis CL, Vigod SN (2018) Chronic medical conditions and peripartum mental illness: a systematic review and meta-analysis. Am J Epidemiol 187(9):2060–2068. https://doi.org/10.1093/aje/kwy080
Blom EA, Jansen PW, Verhulst FC et al (2010) Perinatal complications increase the risk of postpartum depression. The Generation R Study. BJOG 117(11):1390–1398. https://doi.org/10.1111/j.1471-0528.2010.02660.x
Arafa A, Dong JY (2019) Gestational diabetes and risk of postpartum depressive symptoms: a meta-analysis of cohort studies. J Affect Disord 253:312–316. https://doi.org/10.1016/j.jad.2019.05.001
Caropreso L, de Azevedo CT, Eltayebani M, Frey BN (2020) Preeclampsia as a risk factor for postpartum depression and psychosis: a systematic review and meta-analysis. Arch Womens Ment Health 23(4):493–505. https://doi.org/10.1007/s00737-019-01010-1
Roberts L, Davis GK, Homer CSE (2019) Depression, anxiety and post-traumatic stress disorder following a hypertensive disorder of pregnancy: a narrative literature review. Front Cardiovasc Med 6:147. https://doi.org/10.3389/fcvm.2019.00147
Li Y, Kurinczuk JJ, Gale C, Siassakos D, Carson C (2022) Evidence of disparities in the provision of the maternal postpartum 6-week check in primary care in England, 2015–2018: an observational study using the Clinical Practice Research Datalink (CPRD). J Epidemiol Community Health 76(3):239–246. https://doi.org/10.1136/jech-2021-216640
Shankar M, Chan CS, Frayne SM, Panelli DM, Phibbs CS, Shaw JG (2021) Postpartum transition of care: racial/ethnic gaps in veterans’ re-engagement in VA primary care after pregnancy. Womens Health Issues 31(6):603–609. https://doi.org/10.1016/j.whi.2021.06.003
Rankin KM, Haider S, Caskey R, Chakraborty A, Roesch P, Handler A (2016) Healthcare utilization in the postpartum period among Illinois women with Medicaid paid claims for delivery, 2009–2010. Matern Child Health J 20(Suppl 1):144–153. https://doi.org/10.1007/s10995-016-2043-8
Yelland J, Weetra D, Stuart-Butler D et al (2016) Primary health care for Aboriginal women and children in the year after birth: findings from a population-based study in South Australia. Aust N Z J Public Health 40(5):418–423. https://doi.org/10.1111/1753-6405.12581
Oliver L, Wood M, Frawley C, Almond J, Larkins S (2015) Retrospective audit of postnatal attendance for Aboriginal and Torres Strait Islander women attending a community-controlled health service in north Queensland. Aust Fam Physician 44(4):243–247
Phillips SEK, Celi AC, Wehbe A, Kaduthodil J, Zera CA (2023) Mobilizing the fourth trimester to improve population health: interventions for postpartum transitions of care. Am J Obstet Gynecol 229(1):33–38. https://doi.org/10.1016/j.ajog.2022.12.309
Stumbras K, Rankin K, Caskey R, Haider S, Handler A (2016) Guidelines and interventions related to the postpartum visit for low-risk postpartum women in high and upper middle income countries. Matern Child Health J 20(Suppl 1):103–116. https://doi.org/10.1007/s10995-016-2053-6
Kabakian-Khasholian T, Campbell OMR (2005) A simple way to increase service use: triggers of women’s uptake of postpartum services. BJOG 112(9):1315–1321. https://doi.org/10.1111/j.1471-0528.2004.00507.x
4th Trimester Project: New mom health (2024). https://newmomhealth.com/. Accessed March 26, 2024.
Kurtz Landy C, Jack SM, Wahoush O, Sheehan D, MacMillan HL, NFP Hamilton Research Team (2012) Mothers’ experiences in the Nurse-Family Partnership program: a qualitative case study. BMC Nurs 11:15. https://doi.org/10.1186/1472-6955-11-15
Stevens-Simon C, O’Connor P, Bassford K (1994) Incentives enhance postpartum compliance among adolescent prenatal patients. J Adolesc Health 15(5):396–399. https://doi.org/10.1016/1054-139x(94)90263-1
Mendez-Figueroa H, Daley J, Breault P et al (2014) Impact of an intensive follow-up program on the postpartum glucose tolerance testing rate. Arch Gynecol Obstet 289(6):1177–1183. https://doi.org/10.1007/s00404-014-3157-0
Marsiglia FF, Bermudez-Parsai M, Coonrod D (2010) Familias Sanas: an intervention designed to increase rates of postpartum visits among Latinas. J Health Care Poor Underserved 21(3 Suppl):119–131. https://doi.org/10.1353/hpu.0.0355
Himes KP, Donovan H, Wang S, Weaver C, Grove JR, Facco FL (2017) Healthy beyond pregnancy, a web-based intervention to improve adherence to postpartum care: randomized controlled feasibility trial. JMIR Hum Factors 4(4):e7964. https://doi.org/10.2196/humanfactors.7964
Glassgow AE, Wagner-Schuman M, Knepper A et al (2023) Addressing maternal health disparities: building a novel Two-Generation approach to comprehensive postpartum care. Popul Health Manag 26(5):275–282. https://doi.org/10.1089/pop.2023.0059
Sadural E, Riley KE, Zha P, Pacquiao D, Faust A (2022) Experiences with a postpartum mHealth intervention during the COVID-19 pandemic: key informant interviews among patients, health care providers, and stakeholders. JMIR Form Res 6(6):e37777. https://doi.org/10.2196/37777
Yee LM, Martinez NG, Nguyen AT, Hajjar N, Chen MJ, Simon MA (2017) Using a patient navigator to improve postpartum care in an urban women’s health clinic. Obstet Gynecol 129(5):925–933. https://doi.org/10.1097/AOG.0000000000001977
Bowden ER, Chang AB, McCallum GB (2023) Interventions to improve enablers and/or overcome barriers to seeking care during pregnancy, birthing and postnatal period for women living with vulnerabilities in high-income countries: a systematic review and meta-analysis. Midwifery 121:103674. https://doi.org/10.1016/j.midw.2023.103674
Hirshberg A, Downes KM, Srinivas S (2018) Comparing standard office-based follow-up with text-based remote monitoring in the management of postpartum hypertension: a randomised clinical trial. BMJ Qual Saf 27(11):871–877. https://doi.org/10.1136/bmjqs-2018-007837
Tovar A, Chasan-Taber L, Eggleston E, Oken E (2011) Postpartum screening for diabetes among women with a history of gestational diabetes mellitus. Prev Chronic Dis 8:A124
Jones EJ, Hernandez TL, Edmonds JK, Ferranti EP (2019) Continued disparities in postpartum follow-up and screening among women with gestational diabetes and hypertensive disorders of pregnancy: a systematic review. J Perinat Neonatal Nurs 33(2):136–148. https://doi.org/10.1097/JPN.0000000000000399
Bernstein JA, Quinn E, Ameli O et al (2017) Follow-up after gestational diabetes: a fixable gap in women’s preventive healthcare. BMJ Open Diabetes Res Care 5(1):e000445. https://doi.org/10.1136/bmjdrc-2017-000445
Suresh SC, Duncan C, Kaur H et al (2021) Postpartum outcomes with systematic treatment and management of postpartum hypertension. Obstet Gynecol 138(5):777–787. https://doi.org/10.1097/AOG.0000000000004574
Levine LD, Nkonde-Price C, Limaye M, Srinivas SK (2016) Factors associated with postpartum follow-up and persistent hypertension among women with severe preeclampsia. J Perinatol 36(12):1079–1082. https://doi.org/10.1038/jp.2016.137
Ehrenthal DB, Maiden K, Rogers S, Ball A (2014) Postpartum healthcare after gestational diabetes and hypertension. J Womens Health (Larchmt) 23(9):760–764. https://doi.org/10.1089/jwh.2013.4688
Morrison MK, Collins CE, Lowe JM (2009) Postnatal testing for diabetes in Australian women following gestational diabetes. Aust N Z J Obstet Gynaecol 49(5):494–498. https://doi.org/10.1111/j.1479-828X.2009.01056.x
Chamberlain C, McLean A, Oats J et al (2015) Low rates of postpartum glucose screening among indigenous and non-indigenous women in Australia with gestational diabetes. Matern Child Health J 19(3):651–663. https://doi.org/10.1007/s10995-014-1555-3
Marschner S, Cheung NW, Wing-Lun E, Kazi S, Trivedi R, Chow CK (2024) Primary care management post gestational diabetes in Australia. Intern Med J 54(1):164–171. https://doi.org/10.1111/imj.16106
Hutchesson M, Shrewsbury V, Park F, Callister R, Collins C (2018) Are women with a recent diagnosis of pre-eclampsia aware of their cardiovascular disease risk? A cross-sectional survey. Aust N Z J Obstet Gynaecol 58(6):E27–E28. https://doi.org/10.1111/ajo.12900
Hunt KJ, Conway DL (2008) Who returns for postpartum glucose screening following gestational diabetes mellitus? Am J Obstet Gynecol 198(4):404.e1-404.e6. https://doi.org/10.1016/j.ajog.2007.09.015
Castling ZA, Farrell T (2019) An analysis of demographic and pregnancy outcome data to explain non-attendance for postpartum glucose testing in women with gestational diabetes mellitus: why are patients missing follow-up? Obstet Med 12(2):85–89. https://doi.org/10.1177/1753495X18797201
Celi AC, Seely EW, Wang P, Thomas AM, Wilkins-Haug LE (2019) Caring for women after hypertensive pregnancies and beyond: implementation and integration of a postpartum transition clinic. Matern Child Health J 23:1459–1466. https://doi.org/10.1007/s10995-019-02768-7
Sterne VL, Logan T, Palmer MA (2011) Factors affecting attendance at postpartum diabetes screening in women with gestational diabetes mellitus. Pract Diabetes Int 28(2):64–68a. https://doi.org/10.1002/pdi.1559
Van Ryswyk EM, Middleton PF, Hague WM, Crowther CA (2016) Women’s views on postpartum testing for type 2 diabetes after gestational diabetes: six month follow-up to the DIAMIND randomised controlled trial. Prim Care Diabetes 10(2):91–102. https://doi.org/10.1016/j.pcd.2015.07.003
Dietz PM, Vesco KK, Callaghan WM et al (2008) Postpartum screening for diabetes after a gestational diabetes mellitus-affected pregnancy. Obstet Gynecol 112(4):868–874. https://doi.org/10.1097/AOG.0b013e318184db63
D’Amico R, Dalmacy D, Akinduro JA et al (2023) Patterns of postpartum primary care follow-up and diabetes-related care after diagnosis of gestational diabetes. JAMA Netw Open 6(2):e2254765. https://doi.org/10.1001/jamanetworkopen.2022.54765
Nielsen KK, Kapur A, Damm P, de Courten M, Bygbjerg IC (2014) From screening to postpartum follow-up—the determinants and barriers for gestational diabetes (GDM) services, a systematic review. BMC Pregnancy Childbirth 14:1–18. https://doi.org/10.1186/1471-2393-14-41
Ditosto JD, Roytman MV, Dolan BM, Khan SS, Niznik CM, Yee LM (2023) Improving postpartum and long-term health after an adverse pregnancy outcome: examining interventions from a health equity perspective. Clin Obstet Gynecol 66(1):132–149. https://doi.org/10.1097/GRF.0000000000000759
Stasenko M, Liddell J, Cheng YW, Sparks TN, Killion M, Caughey AB (2011) Patient counseling increases postpartum follow-up in women with gestational diabetes mellitus. Am J Obstet Gynecol 204(6):522.e1-522.e6. https://doi.org/10.1016/j.ajog.2011.01.057
Shea AK, Shah BR, Clark HD et al (2011) The effectiveness of implementing a reminder system into routine clinical practice: does it increase postpartum screening in women with gestational diabetes. Chronic Dis Can 31:58–64. https://doi.org/10.24095/hpcdp.31.2.02
Huynh T, Ghaffari N, Bastek J, Durnwald C (2017) Prenatal care in a specialized diabetes in pregnancy program improves compliance with postpartum testing in GDM women. J Matern Fetal Neonatal Med 30(9):1075–1079. https://doi.org/10.1080/14767058.2016.1201472
Tsai PJS, Nakashima L, Yamamoto J, Ngo L, Kaneshiro B (2011) Postpartum follow-up rates before and after the postpartum follow-up initiative at Queen Emma clinic. Hawaii Med J 70(3):56–59
Schwartz J, Bocour A, Tang L et al (2021) Telephone patient navigation increases follow-up hepatitis B care in the postpartum period for immigrants living in New York City. J Immigr Minor Health 23(6):1179–1186. https://doi.org/10.1007/s10903-021-01240-5
Clark HD, Graham ID, Karovitch A, Keely EJ (2009) Do postal reminders increase postpartum screening of diabetes mellitus in women with gestational diabetes mellitus? A randomized controlled trial. Am J Obstet Gynecol 200(6):e1–e7. https://doi.org/10.1016/j.ajog.2009.01.003
Lega IC, McLaughlin H, Coroneos M, Handley-Derry F, Donovan N, Lipscombe LL (2012) A physician reminder to improve postpartum diabetes screening in women with gestational diabetes mellitus. Diabetes Res Clin Pract 95(3):352–357. https://doi.org/10.1016/j.diabres.2011.10.023
Triebwasser JE, Lewey J, Walheim L, Sehdev HM, Srinivas SK (2023) Electronic reminder to transition care after hypertensive disorders of pregnancy: a randomized controlled trial. Obstet Gynecol 142(1):91–98. https://doi.org/10.1097/AOG.0000000000005237
Van Ryswyk EM, Middleton PF, Hague WM, Crowther CA (2015) Postpartum SMS reminders to women who have experienced gestational diabetes to test for Type 2 diabetes: the DIAMIND randomized trial. Diabet Med 32(10):1368–1376. https://doi.org/10.1111/dme.12769
Countouris M, Restrepo VJ, Bidani S et al (2022) Feasibility of utilizing telehealth in a multidisciplinary postpartum hypertension clinic. Womens Health Rep (New Rochelle) 3(1):877–886. https://doi.org/10.1089/whr.2022.0066
Soffer MD, Rekawek P, Pan S, Overbey J, Stone J (2023) Improving postpartum attendance among women with gestational diabetes using the medical home model of care. Am J Perinatol 40(3):313–318. https://doi.org/10.1055/s-0041-1727216
Hoppe KK, Williams M, Thomas N et al (2019) Telehealth with remote blood pressure monitoring for postpartum hypertension: a prospective single-cohort feasibility study. Pregnancy Hypertens 15:171–176. https://doi.org/10.1016/j.preghy.2018.12.007
Bose Brill S, May S, Lorenz AM et al (2022) Mother-Infant Dyad program in primary care: evidence-based postpartum care following gestational diabetes. J Matern Fetal Neonatal Med 35(25):9336–9341. https://doi.org/10.1080/14767058.2022.2032633
Vesco KK, Dietz PM, Bulkley J et al (2012) A system-based intervention to improve postpartum diabetes screening among women with gestational diabetes. Am J Obstet Gynecol 207(4):283.e1-e6. https://doi.org/10.1016/j.ajog.2012.08.017
Ukoha EP, Davis K, Yinger M et al (2021) Ensuring equitable implementation of telemedicine in perinatal care. Obstet Gynecol 137(3):487–492. https://doi.org/10.1097/AOG.0000000000004276
Bennett WL, Ennen CS, Carrese JA et al (2011) Barriers to and facilitators of postpartum follow-up care in women with recent gestational diabetes mellitus: a qualitative study. J Womens Health (Larchmt) 20(2):239–245. https://doi.org/10.1089/jwh.2010.2233
Funding
Open Access funding enabled and organized by CAUL and its Member Institutions. The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation was performed by Naomi Whyler. The first draft of the manuscript was written by Naomi Whyler and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript. N Whyler: Project development, Manuscript writing. S Krishnaswamy: Project development, Manuscript editing. S Price: Project development, Manuscript editing. M Giles: Project development, Manuscript editing.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no relevant financial or non-financial interests to disclose.
Disclosure
The authors recognize that a person who physically experiences pregnancy and undergoes transition to postpartum care may have a gender identity other than female. For clarity in this review, the term woman is used when referring to the individual who physically experienced pregnancy and postpartum care. The term partner is used when referring to a significant other and is intended to include all self-identified genders.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Whyler, N.C.A., Krishnaswamy, S., Price, S. et al. Strategies to improve postpartum engagement in healthcare after high-risk conditions diagnosed in pregnancy: a narrative review. Arch Gynecol Obstet 310, 69–82 (2024). https://doi.org/10.1007/s00404-024-07562-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-024-07562-7